1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar : September 21 - September 27, 2025
  1. Public Calendar - Meetings With FDA Officials

Public Calendar : September 21 - September 27, 2025

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs
Event Date: 09/22/2025
Location: Silver Spring, MD
Subject: Fostering a More Efficient Drug Development System
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Oncology practitioners, academia, and other stakeholders

Event Date: 09/26/2025
Location: Atlanta, GA
Subject: CEO Forums: FDA National Listening Tour with Pharmaceutical and Biotech
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry

Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs
Event Date: 09/23/2025
Location: Washington, DC
Subject: Regulatory Submissions with Real-World Evidence: Successes, Challenges, and Lessons Learned FDA Public Meeting; Speaker: Opening Remarks
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Official Name: Sean R. Keveney, Chief Counsel
No Significant Event

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs
Event Date: 09/24/2025
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Tom Barton (White Rock Capital);

Event Date: 09/26/2025
Location: Virtual
Subject: 7-hydroxymitragynine (7-OH) Issues
FDA Participant/Group: NICHOLAS ALEXANDER; MARTA SOKOLOWSKA;
Non FDA Participant/Group: Erin Reed, Matt Donahue, Nikki Guilford (Ohio Governor's Office);

Event Date: 09/26/2025
Location: Virtual
Subject: Alexandria Summit Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Mark McClellan, Martha Reguard (Duke University); Carrie Benninger (Alexandria Real Estate Equities); Lynne Zydowsky (Zydowsky Consultants);

Event Date: 09/26/2025
Location: Rockville, MD
Subject: Bilateral Meeting
FDA Participant/Group: RAVI BHARWANI;
Non FDA Participant/Group: Alex Dodoo, Delese Mimi Darko (African Medicines Agency);

Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Human Foods
Event Date: 09/22/2025
Location: Monterey, CA
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: California Department of Food and Agriculture, Western Growers, California Leafy Greens Marketing Agreement, Monterey County Farm Bureau, academia, and produce farmers

Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations
No Significant Event

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives
No Significant Event

Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations
No Significant Event

Official Name: Vinayak Prasad, M.D., M.P.H., Director, Center for Biologics and Research
No Significant Event

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health
Event Date: 09/25/2025
Location: King of Prussia, PA
Subject: Pennsylvania Life Sciences Conference; Speaker: Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, academia, and other stakeholders

Event Date: 09/26/2025
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Google representatives

Event Date: 09/26/2025
Location: Virtual
Subject: 3D Dartmouth Device Development Symposium; Speaker: Session XI A Conversation with the Director
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, academia, and other stakeholders

Official Name: George F. Tidmarsh, M.D., Ph.D., Director, Center for Drug Evaluation and Research
Event Date: 09/25/2025
Location: Silver Spring, MD
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Giuseppe Randanzo (Association for Accessible Medicines (AAM));

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products
No Significant Event

Official Name: Timothy Schell, Ph.D., Director, Center for Veterinary Medicine
No Significant Event

Back to Top